Imatinib
Total Payments
$14,750
Transactions
3
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $14,750 | 3 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $14,750 | 3 | 100.0% |
Top Doctors Receiving Payments for Imatinib
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Hematology & Oncology | Houston, TX | $14,750 | 3 |
Ad
Manufacturing Companies
- West-Ward Pharmaceuticals $14,750
Product Information
- Type Drug
- Total Payments $14,750
- Total Doctors 1
- Transactions 3
About Imatinib
Imatinib is a drug associated with $14,750 in payments to 1 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is West-Ward Pharmaceuticals.
Payment data is available from 2017 to 2017. In 2017, $14,750 was paid across 3 transactions to 1 doctors.
The most common payment nature for Imatinib is "Honoraria" ($14,750, 100.0% of total).